Month: January 2022

COMPANY ANNOUNCEMENT NO. 1-202227 January 2022, Copenhagen, DenmarkFull year 2021 preliminary revenue exceeds latest financial guidance provided on 11 November 2021 in Company Announcement No. 17-2021. This was primarily driven by the Capital business in Q4 2021. Preliminary and unaudited key figures for Q4 and full year 2021  Q4 2021 FY 2021 FY 2021 guidanceRevenue (DKK bn) 5.1 17.6 16.0-17.0EBITA margin 6.6% 5.9% 5-6%The Q4 and full year 2021 results include costs related to the thyssenkrupp Mining acquisition of around DKK 37m and around DKK 107m, respectively. Subject to regulatory approval, closing of the transaction is still expected in the second half of 2022. FLSmidth will, as previously communicated, release the detailed and audited financial results for the full year of 2021 on 16 February 2022.    Contacts:Investor...

Invitation to presentation of Sdiptech’s Year-End Report for 2021 Sdiptech AB (publ) will publish its interim report for the Year-End Report 2021 on Thursday, 10 February 2022 at 08:00 CET and invites you to a presentation via a webcast conference call on the same date at 14.00 CET. Sdiptech’s CEO Jakob Holm and CFO Bengt Lejdström will present the report and answer questions. The presentation will be held in English. Webcast presentationThe transmission can be viewed via the following link: https://www.finwire.tv/webcast/sdiptech/q4-2021/ The presentation slides used will be available during the webcast and will be published on the company’s website, www.sdiptech.se, before the start of the presentation. For further information, please contact: Bengt Lejdström, CFO, +46 702 74 22 00, bengt.lejdstrom@sdiptech.comMy Lundberg,...

WOBURN, Mass., Jan. 27, 2022 (GLOBE NEWSWIRE) — NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and full year ended December 31, 2021. The Company’s mission is to reduce the impact of neurological disorders and pain syndromes on individuals and on population health through innovative non-invasive medical devices. Highlights:Q4 revenue of $1.8 million was up slightly from Q4 2020. Full year revenue of $8.3 million increased by 11.9% from the prior year. DPNCheck® sales into Medicare Advantage was the primary contributor to revenue. On a full year basis, it posted revenue growth of 26.0% Q4 gross margin on revenue was $1.2 million compared to $1.3 million in Q4 2020. The gross margin rate of 68.3% was down from 73.7% in the prior year quarter. Incremental spending to secure...

Fourth quarter 2021 GAAP earnings per share of $0.18 including a one-time $0.09 per share deferred tax provision related to a change in Louisiana tax lawFourth quarter 2021 adjusted earnings per share of $0.27Solid improvement in inland marine with barge market strengthening and operating margins approaching 10%Distribution and services activity sequentially lower due to supply chain delays and seasonalityMeaningful improvement expected in 2022 in both inland marine and distribution and services2022 projected cash flow from operations of $400 million to $480 million and capital expenditures of $170 to $190 millionHOUSTON, Jan. 27, 2022 (GLOBE NEWSWIRE) — Kirby Corporation (“Kirby”) (NYSE: KEX) today announced net earnings attributable to Kirby for the fourth quarter ended December 31, 2021 of $11.0 million or $0.18...

Results Support Favorable Safety and Tolerability Profile and Target Engagement of GB0139 and Potential for GB0139 in Severe Lung Disease Company Provides Update on GALACTIC-1 Trial BOSTON, Jan. 27, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced the publication of the full results of an investigator-initiated open and randomized trial to evaluate Galecto’s inhaled galectin-3 inhibitor, GB0139, in hospitalized patients with COVID-19 infection who required oxygen but not mechanical ventilation, compared to patients only on standard of care. Galectin-3 plays a key role in COVID-19-related acute lung injury, cytokine storm, T-cell exhaustion and organ micro-thrombosis, and the results from this trial...

TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 27, 2022 (GLOBE NEWSWIRE) — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has appointed Dr. Cheryl Wellington to its scientific advisory board (SAB). Dr. Cheryl Wellington, Professor of Pathology and Laboratory Medicine at the University of British Columbia (UBC), has built an internationally recognized research program that focuses on neurological diseases, with a particular emphasis on Alzheimer’s Disease (AD) and Traumatic Brain Injury (TBI).  “We are delighted to welcome Dr. Wellington to the ProMIS SAB,” stated Dr. Neil Cashman, ProMIS’ Chief Scientific...

THE WOODLANDS, Texas, Jan. 27, 2022 (GLOBE NEWSWIRE) — ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today that UNBRIDLED® ESP Systems has introduced the HIGH RISE™ series pump line, which is engineered to significantly improve electrical submersible pumping (ESP) system performance and longevity while also meaningfully reducing the carbon footprint of ESP operations. HIGH RISE pumps feature patented Oculus™ technology, which allows the pumps to achieve up to 33% greater lift per unit length of pump. Higher lift per stage means fewer components in the well and faster installs to minimize rig time while also reducing the overall carbon footprint of an ESP system. The HIGH RISE pump series also covers an extended production range from 200 to 7,500 BPD. “The Oculus technology feature in our HIGH RISE...

NEW YORK, Jan. 27, 2022 (GLOBE NEWSWIRE) — OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced Alpine Summit Energy Partners, Inc. (TSX-V: ALPS.U; OTCQX: ASEPF), an energy developer and financial company focused on maximizing growth and return on equity via improved access to wellhead economics, has qualified to trade on the OTCQX® Best Market. Alpine Summit Energy Partners, Inc. upgraded to OTCQX from the OTCQB® Venture Market. Alpine Summit Energy Partners, Inc. begins trading today on OTCQX under the symbol “ASEPF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com. The OTCQX Market is designed for established, investor-focused U.S. and international companies. To qualify for OTCQX,...

TORONTO and KNOXVILLE, Tenn., Jan. 27, 2022 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR, OTCQB: SAENF) is pleased to announce it has signed a contract with AESSEAL, a specialist in the design and manufacture of mechanical seals and support systems, for a 526-kilowatt (“kW”) roof mount solar system at AESSEAL’s U.S. headquarters in Rockford, Tennessee. Solar Alliance will design, engineer and install the project, which is scheduled to begin construction in April and is targeted for completion by the end of October 2022. “Solar Alliance is proud to have been selected to deliver this 526-kW project for AESSEAL in Tennessee,” said Solar Alliance CEO Myke Clark. “This solar project is a testament to AESSEAL’s commitment to sustainable business practices and also to reducing their operating...

Quarterly Cash Dividend Increased to $0.16 per Share Fourth Quarter HighlightsNet income of $13.6 million, or $0.47 per diluted share; return on average assets (ROAA) of 1.26%; return on average stockholders’ equity (ROAE) of 13.15%; and return on average tangible common equity (ROATCE)(1) of 14.24% Adjusted net income(1) of $14.2 million; or $0.49 per diluted share; adjusted ROAA(1) of 1.32%; adjusted ROAE(1) of 13.70%; and adjusted ROATCE(1) of 14.83%(1)   See “Reconciliation of Non-GAAP Financial Measures” below for reconciliation of non-GAAP financial measures to their most closely comparable GAAP financial measures. BLOOMINGTON, Ill., Jan. 27, 2022 (GLOBE NEWSWIRE) — HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial” or “HBT”), the holding company for Heartland Bank and Trust Company,...